TY - JOUR
T1 - Evaluating stress, satisfaction and the associated influencing factors of participants in cancer clinical trials
T2 - A cross-sectional study in China
AU - Jiang, Shiyu
AU - Liu, Peng
AU - Yang, Sheng
AU - Yang, Jianliang
AU - Wu, Dawei
AU - Fang, Hong
AU - Qin, Yan
AU - Zhou, Shengyu
AU - Xu, Jianping
AU - Sun, Yongkun
AU - Mo, Hongnan
AU - Gui, Lin
AU - Xing, Puyuan
AU - Lan, Bo
AU - Zhang, Bo
AU - Tang, Le
AU - Sun, Yan
AU - Shi, Yuankai
N1 - Funding Information:
Funding This study was was supported by the grants from Chinese National Major Project for New Drug Innovation(2017ZX09304015).
Publisher Copyright:
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
PY - 2019/5/1
Y1 - 2019/5/1
N2 - Objectives Patients' stress and satisfaction concerning cancer clinical trials (CCT) may affect study accrual and quality. Our study aimed to evaluate stress and satisfaction in CCT and the influencing factors. Design Cross-sectional analysis done by a questionnaire after informed consent. Setting Cancer Hospital, Chinese Academy of Medical Sciences. Participants 199 CCT participants. Primary and secondary outcome measures self-assessed stress and satisfaction in CCT. Results Among 199 participants, 83.9% would join CCT again; 72.9% had enough time to decide on trial participation; 73.9% claimed complete awareness of CCT; 3.5% doubted CCT's significance and scientific quality; 33.2% deemed CCT time-consuming; 73.9% scored satisfaction ≥9/10; and 25.6% claimed moderate to severe stress. Positive factors for satisfaction were enough decision time (OR=0.36, p=0.0003), better impressions of doctors (OR=0.41, p=0.047) and less time-consuming trials (OR=0.43, p<0.0001). Individuals with more prior uninsured medical expenses (OR=1.23, p=0.026), less time consumption (OR=2.35, p<0.0001) and more tests in CCT (OR=0.64, p=0.035) were less likely to experience stress. Phase III study participants bore less stress than phase II (OR=0.29, p=0.032) but more than phase I (OR=1.18, p=0.009). Conclusions Our study addressed factors influencing CCT participants' stress and satisfaction. We suggested measures to improve patients' experiences in CCT. Trial registration number NCT03412344; Pre-results.
AB - Objectives Patients' stress and satisfaction concerning cancer clinical trials (CCT) may affect study accrual and quality. Our study aimed to evaluate stress and satisfaction in CCT and the influencing factors. Design Cross-sectional analysis done by a questionnaire after informed consent. Setting Cancer Hospital, Chinese Academy of Medical Sciences. Participants 199 CCT participants. Primary and secondary outcome measures self-assessed stress and satisfaction in CCT. Results Among 199 participants, 83.9% would join CCT again; 72.9% had enough time to decide on trial participation; 73.9% claimed complete awareness of CCT; 3.5% doubted CCT's significance and scientific quality; 33.2% deemed CCT time-consuming; 73.9% scored satisfaction ≥9/10; and 25.6% claimed moderate to severe stress. Positive factors for satisfaction were enough decision time (OR=0.36, p=0.0003), better impressions of doctors (OR=0.41, p=0.047) and less time-consuming trials (OR=0.43, p<0.0001). Individuals with more prior uninsured medical expenses (OR=1.23, p=0.026), less time consumption (OR=2.35, p<0.0001) and more tests in CCT (OR=0.64, p=0.035) were less likely to experience stress. Phase III study participants bore less stress than phase II (OR=0.29, p=0.032) but more than phase I (OR=1.18, p=0.009). Conclusions Our study addressed factors influencing CCT participants' stress and satisfaction. We suggested measures to improve patients' experiences in CCT. Trial registration number NCT03412344; Pre-results.
KW - cancer
KW - clinical trials
KW - patient satisfaction
KW - stress
UR - http://www.scopus.com/inward/record.url?scp=85066757871&partnerID=8YFLogxK
U2 - 10.1136/bmjopen-2018-028589
DO - 10.1136/bmjopen-2018-028589
M3 - Article
C2 - 31154312
AN - SCOPUS:85066757871
SN - 2044-6055
VL - 9
JO - BMJ Open
JF - BMJ Open
IS - 5
M1 - e028589
ER -